NCT00423007已完成3 期
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With a History of Allergic Conjunctivitis
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- Treatment of ocular itching
研究概览
简要总结
The primary objective of this study is to investigate the efficacy and safety of bromfenac ophthalmic solution for treatment in subjects with a history of allergic conjunctivitis
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 10 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •History of clinically active allergic conjunctivitis
- •Agree to return for all required visits
- •Agree to avoid disallowed meds
排除标准
- •Known hypersensitivity to bromfenac and salicylates
研究组 & 干预措施
Bromfenac
Experimental
Ophthalmic Solution
干预措施: Bromfenac (Drug)
Placebo
Placebo Comparator
Vehicle ophthalmic solution
干预措施: Placebo (Drug)
结局指标
主要结局
Treatment of ocular itching
次要结局
- Treatment of chemosis, episcleral and ciliary hyperemia, ocular mucous discharge, eyelid swelling, foreign body sensation, nasal symptoms, and/or tearing
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract SurgeryPainInflammationNCT00333918Bausch & Lomb Incorporated522
已完成
3 期
Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract SurgeryPostoperative ComplicationsCataractNCT00198445Bausch & Lomb Incorporated527
已完成
2 期
Efficacy and Safety of Bromfenac Ophthalmic SolutionCataract SurgeryNCT00585975Bausch & Lomb Incorporated568
已完成
3 期
Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract SurgeryPainInflammationCataractNCT01367249Bausch & Lomb Incorporated440
已完成
3 期
Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract SurgeryPainInflammationNCT00853970Bausch & Lomb Incorporated299